PSA has announced its new board, including its new Early Career Pharmacist Director
High-achieving pharmacist Lauren Burton’s appointment as the new Early Career Pharmacist Director of PSA reaffirms the Board’s commitment to the future of the profession, PSA says.
Ms Burton’s appointment, effective from 1 July 2018, follows the retirement of the Board’s first ECP Director Taren Gill, who has completed her term as an ECP.
PSA National President Dr Shane Jackson and Vice Presidents Michelle Lynch and Dr Chris Freeman were also re-elected to the National Board from 1 July 2018, which the PSA says demonstrates the Board’s stability at a time when the organisation is implementing many initiatives to improve the role and recognition of pharmacists in healthcare.
Dr Jackson says he is delighted to welcome Ms Burton to the National Board, and sincerely thanked Ms Gill for her service.
“Taren’s appointment as the first ECP Director two years ago was an historic milestone for PSA,” Dr Jackson says.
“She has worked tirelessly to support ECPs across the country, and led PSA’s strategy to meet the future needs of the profession with ground-breaking initiatives such as the ECP White Paper.
“PSA recognises the importance of diversity on our Board and Lauren will continue to lead our strong focus on ECPs.
“Lauren is a talented and deeply passionate pharmacist and I am confident she will make a fantastic contribution to the Board. Her extensive experience in a range of pharmacy roles will help ensure PSA’s strategy meets the needs of Australia’s ECPs so they can be confident in the bright future ahead.”
Ms Burton has significant experience in community and hospital pharmacy, more recently in roles involving project-based work, clinical pharmacy and dispensary services as a member of the Pharmacy Department at Sir Charles Gairdner Hospital, Perth WA. She also has experience in reviewing and informing legislation as well as government and hospital policies.
“As part of PSA’s White Paper Working Group, I have heard our members and developed an in-depth understanding of the key issues facing ECPs,” Ms Burton says.
“I am passionate about improving awareness of the role of the pharmacist as part of a healthcare team and believe this will enable the progression of key initiatives for expanding our role as medicines management experts.
“I intend to ensure the issues discussed and recommendations put forward in the ECP White Paper continue to frame conversations around how PSA and its networks can best support pharmacists now and into the future.
“Our members have shown their support and appreciation for the role Taren Gill has played as ECP Director over the past two years. I have been lucky enough to get to know Taren during this time and have seen the positive influence her passion, leadership and commitment have had on so many within our profession.”